With omicron still causing hundreds of thousands of new COVID cases each day, it’s understandable that, for some people, getting infected is starting to feel inevitable. Getting a COVID booster may be the best thing you can do to protect yourself.
As SELF has reported, vaccines are the best way to prevent severe COVID outcomes like hospitalization and death. But research also shows that vaccine protection may wane over time. Enter the need for a third dose to boost antibody levels back up. As the omicron variant began to surge, it became especially clear that two doses may not be enough to keep you from getting the highly contagious variant. In December, vaccine makers Pfizer and BioNTech released research which found that while two doses of the vaccine still offered protection against “severe forms of the disease,” they were significantly less effective at preventing infection.
As omicron has continued to spread—it’s now responsible for 99.9% of all COVID infections in the U.S., per CNN—scientists have been working to figure out just how well the COVID booster protects against mild infections as well as severe COVID outcomes. This week, vaccine maker Moderna published a new study in the New England Journal of Medicine, which found two important things: Six months after the booster shot, antibody protection had waned, but ultimately it was still effective in protecting against the virus.
READ RELATED: Best supplements for sleep: Six vitamins and minerals for a better night’s sleep
Moderna’s study found, similar to the results of the Pfizer BioNTech study, that anti-COVID antibodies waned significantly in the months after the second vaccine dose. In analyzing blood samples of people who received the Moderna vaccine, researchers found that antibody levels capable of neutralizing omicron were found in 85% of people a month after their second dose. But by seven months, neutralization of omicron was found in only 55% of people. Getting a third dose turned things around somewhat. Researchers reported a 20-fold increase in omicron-neutralizing antibodies a month after the booster.
But did the booster protection eventually wane as well? It did, according to the study, but not by as much. Six months after the booster shot, antibody protection was just over six times lower than after it was first administered—something researchers expected. “This is not uncommon, for mRNA vaccines or for vaccines in general,” Dave Montefiori, Ph.D., a professor in Duke University’s department of surgery and coauthor on the Moderna study, told CNN. “Antibodies go down because the body figures it does not need to maintain them at that high level. It doesn’t mean there is no protection. There is immunologic memory.” To that point, another lab study from Pfizer, which was published earlier this week, found that four months after a booster dose, antibody levels were still high enough to protect against omicron, The Washington Post reported.
Despite all of this, as SELF previously reported, only 67% of the eligible population is fully vaccinated (which the Centers for Disease Control and Prevention currently defines as having received two primary doses of the Pfizer or Moderna vaccines or one shot of the single dose Johnson & Johnson vax), according to the CDC. And of those vaccinated people, only 40% have gotten their booster.
Source: SELF
